Cannabidiol (CBD) Consideration in Parkinson Disease

Parkinson disease (PD) is a progressive neurodegenerative disorder characterized by the decrease in dopaminergic neurons in the brain leading to motor and nonmotor symptoms. With the increased availability of cannabidiol in the United States and interest in the PD community for PD-related symptom ma...

Full description

Saved in:
Bibliographic Details
Published in:Journal for nurse practitioners 2022-06, Vol.18 (6), p.611-613
Main Authors: Kim, Helen, Zhang, Sharon, Sin, Mo-Kyung
Format: Article
Language:English
Subjects:
Antidepressants
Brain research
Cannabidiol
Clinical trials
Cognition & reasoning
Constipation
Deep brain stimulation
Dementia
Dopamine
Drug interactions
Gait
Insomnia
Mental depression
Neurons
Nurse practitioners
Parkinson disease
Parkinson's disease
Patients
Psychotropic drugs
Symptom management
Tetrahydrocannabinol
THC
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Parkinson disease (PD) is a progressive neurodegenerative disorder characterized by the decrease in dopaminergic neurons in the brain leading to motor and nonmotor symptoms. With the increased availability of cannabidiol in the United States and interest in the PD community for PD-related symptom management in complementary to pharmacologic treatment, this review provides nurse practitioners with useful information on existing studies and regulatory considerations on the implication of cannabidiol in PD. •Parkinson disease (PD) leads to many noticeable motor and nonmotor symptoms.•Pharmacologic treatments for PD symptoms have been found to be especially helpful when combined with nonpharmacologic approaches.•Cannabidiol has been used for PD symptom management.•However, more human model randomized clinical trials are needed for cannabidiol use in PD.
ISSN:1555-4155
1878-058X
DOI:10.1016/j.nurpra.2022.04.006